Back
Agenus 10K Form
Sell
27
AGEN
Agenus
Last Price:
3.35
Seasonality Move:
3.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | AGEN/Agenus Quarterly |
| 2023-11-09 | 10Q | AGEN/Agenus Quarterly |
| 2023-08-08 | 10Q | AGEN/Agenus Quarterly |
| 2023-05-09 | 10Q | AGEN/Agenus Quarterly |
| 2022-11-08 | 10Q | AGEN/Agenus Quarterly |
| 2022-08-09 | 10Q | AGEN/Agenus Quarterly |
Receive AGEN News And Ratings
See the #1 stock for the next 7 days that we like better than AGEN
AGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $156.31M |
|---|---|
| Cash Flow: | $-53.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-13.48 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -68.77000 |
|---|---|
| Net Income (TTM): | $-227.64M |
| Gross Margin: | $-81.37M |
| Return on Equity: | 0% |
| Return on Assets: | -79.22% |
Agenus Earnings Forecast
Key Agenus Financial Ratios
- The Gross Profit Margin over the past 24 years for AGEN is -52.05%.
- The Selling, General & Administrative Expenses for AGEN have been equal to 50.37% of Gross Profit Margin.
- The Research & Development expenses have been 112.19% of Revenue.
- The Interest Expense is -39.85% of Operating Income.
- The Net Earning history of AGEN is -157.22% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 14 years.
Agenus Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AGEN |
| CUSIP: | 00847G |
| Website: | agenusbio.com |
Debt
| Debt-to-Equity Ratio: | -0.05 |
|---|---|
| Current Ratio: | 0.19 |
| Quick Ratio: | 0.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |